Pneumococcal vaccination for welders: Global deployment within a multi‐national corporation

BACKGROUND: Lobar pneumonia is an occupational disease of welders. This is the first report of global deployment of a pneumococcal vaccination program for welders within a multi‐national corporation. METHODS: Global webinars were conducted to introduce the program. Communication packages translated into all location languages were deployed. All employee welders who had not previously been vaccinated were offered a free single dose of pneumococcal polysaccharide vaccine (PPV23) by on‐site location medical centers during normal working hours. Numbers of vaccinated welders were reported by each location each month. RESULTS: Twelve months after starting the program, 241 of 767 welders have been vaccinated (31%) across six countries. CONCLUSIONS: Global deployment of pneumococcal vaccination for welders can be successfully undertaken by a multi‐national corporation. Adoption of this practice by corporations could reduce the incidence and mortality of pneumonia among welders globally.